Human laboratory and neuroimaging studies in substance use disorders: developing new treatment approaches

Am J Drug Alcohol Abuse. 2007;33(6):765-7. doi: 10.1080/00952990701651549.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Amphetamine-Related Disorders / pathology
  • Antipsychotic Agents / therapeutic use
  • Aripiprazole
  • Brain / pathology*
  • Cocaine-Related Disorders / drug therapy
  • Cocaine-Related Disorders / rehabilitation
  • Diffusion Magnetic Resonance Imaging
  • Hallucinogens
  • Humans
  • N-Methyl-3,4-methylenedioxyamphetamine
  • Piperazines / therapeutic use
  • Quinolones / therapeutic use
  • Substance-Related Disorders / diagnosis
  • Substance-Related Disorders / pathology*
  • Substance-Related Disorders / therapy*

Substances

  • Antipsychotic Agents
  • Hallucinogens
  • Piperazines
  • Quinolones
  • Aripiprazole
  • N-Methyl-3,4-methylenedioxyamphetamine